What is the recommended dosage of Rizatriptan (Maxalt) for adults with migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rizatriptan Dosage for Adults with Migraine

The recommended starting dose of rizatriptan for adults is either 5 mg or 10 mg at migraine onset, with the 10 mg dose providing greater efficacy but slightly higher risk of adverse effects; a second dose may be taken 2 hours after the first if headache returns, with a maximum of 30 mg in 24 hours. 1

Standard Dosing Regimen

Initial Dose:

  • Start with either 5 mg or 10 mg at the onset of migraine symptoms 1
  • The 10 mg dose is more effective than 5 mg, achieving pain-free status in up to 44% of patients at 2 hours compared to 7% with placebo 2
  • Take medication early in the attack while pain is still mild for optimal effectiveness 3

Redosing Protocol:

  • If migraine returns after initial response, a second dose may be administered 2 hours after the first dose 1
  • Maximum daily dose: 30 mg in any 24-hour period 1
  • Limit use to no more than 2 days per week to prevent medication-overuse headache 3

Special Dosing Considerations

Patients Taking Propranolol:

  • Use only the 5 mg dose, with a maximum of 3 doses (15 mg total) in 24 hours 1
  • This adjustment is necessary due to drug interactions that increase rizatriptan blood levels 1

Orally Disintegrating Tablets (Maxalt MLT):

  • Available for patients with significant nausea or vomiting 3
  • Same dosing as standard tablets (5 mg or 10 mg) 3

Treatment Trial Period

Before determining effectiveness:

  • Try rizatriptan for 2-3 migraine episodes before concluding it is ineffective 3
  • If rizatriptan fails after adequate trial, consider switching to a different triptan, as failure of one does not predict failure of others 3

Critical Safety Limitations

Absolute Contraindications:

  • Concurrent use with ergotamine derivatives or within 24 hours of another triptan 3
  • Hemiplegic or basilar migraine 3
  • Coronary artery disease or previous myocardial infarction 3
  • Uncontrolled hypertension 3
  • Current MAOI use 3
  • Impaired hepatic function 3

Frequency Restriction:

  • Never exceed 4 headache treatments per 30-day period on average, as safety beyond this has not been established 1
  • Using acute medications more than twice weekly can lead to medication-overuse headache, creating a vicious cycle of increasing headache frequency 3

Common Adverse Effects

Expected side effects (typically mild and transient):

  • Chest pressure and heaviness 3
  • Throat tightness 3
  • Dizziness, somnolence, and asthenia/fatigue 4, 5
  • These effects usually last 2-3 hours and occur in less than 10% of patients 2

Comparative Efficacy

Rizatriptan 10 mg demonstrates superior efficacy compared to other triptans:

  • More effective than zolmitriptan 2.5 mg or naratriptan 2.5 mg at producing pain-free state at 2 hours 4, 5
  • Provides faster pain relief than oral sumatriptan with greater reduction in nausea 4, 5
  • Up to 77% of patients achieve pain relief at 2 hours with the 10 mg dose 2

When to Escalate or Change Therapy

If rizatriptan is inadequate after proper trial:

  • Consider combination therapy with an NSAID (naproxen 500 mg) for enhanced efficacy 6
  • Switch to a different triptan if rizatriptan fails after 2-3 episodes 3
  • Initiate preventive therapy if requiring acute treatment more than twice weekly 6

References

Research

Rizatriptan in the treatment of migraine.

Clinical therapeutics, 1999

Guideline

Rizatriptan Dosage and Administration for Acute Migraine Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.